Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis

Published:2014-02-15 Issue:2 Volume:3 Page:158-161
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Ito Kiyonori,Ueda Yuichiro,Miyazawa Haruhisa,Kaku Yoshio,Hirai Keiji,Hoshino Taro,Nabata Aoi,Mori Honami,Yoshida Izumi,Ookawara Susumu,Tabei Kaoru

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://link.springer.com/content/pdf/10.1007/s13730-014-0109-2.pdf

Reference13 articles.

1. El-Zawawy H, Mandell BF. Managing gout: how is it different in patients with chronic kidney disease? Cleve Clin J Med. 2010;77:919–28.

2. Okamoto K. A new-generation uric acid production inhibitor febuxostat. Jpn Pharmacol Ther. 2010;38:955–62.

3. Grabowski BA, Khosravan R, Vernillet L, Mulford DJ. Metabolism and excretion of [14C] febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, in healthy male subjects. J Clin Pharmacol. 2011;51:189–201.

4. Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ. Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am J Ther. 2005;12:22–34.

5. Khosravan R, Grabowski BA, Mayer MD, Wu JT, Joseph-Ridge N, Vernillet L. The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase. J Clin Pharmacol. 2006;46:88–102.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023);Bioorganic Chemistry;2024-02

2. Hybridization of molecular docking studies with machine learning based QSAR model for prediction of xanthine oxidase activity;Computational and Theoretical Chemistry;2023-09

3. Two cases report of febuxostat-induced acute liver injury: acute heart failure as a probable risk factor?;Drug and Chemical Toxicology;2023-02-14

4. Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro study;Natural Product Research;2022-10-10

5. Study of quality markers of antiuric acid formula by grey relational analysis;SN Applied Sciences;2021-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3